ROLE OF ENZYMATIC ACTIVATION AND INACTIVATION IN DRUG SELECTIVITY

[1]  M. Esterman,et al.  Metabolism and biochemistry of mycophenolic acid. , 1972, Cancer research.

[2]  N. Sládek.  Therapeutic efficacy of cyclophosphamide as a function of inhibition of its metabolism. , 1972, Cancer research.

[3]  D. Hill,et al.  Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. , 1972, Cancer research.

[4]  H. Borberg,et al.  Characterization of protein and DNA in P815 cells sensitive and resistant to 1- -D-arabinofuranosylcytosine. , 1972, Cancer research.

[5]  N. Sládek.  Therapeutic efficacy of cyclophosphamide as a function of its metabolism. , 1972, Cancer research.

[6]  A. Sartorelli,et al.  Studies of the antineoplastic activity and metabolism of -(N)-heterocyclic carboxaldehyde thiosemicarbazones in dogs and mice. , 1972, Cancer research.

[7]  N. Bachur,et al.  Daunorubicin metabolism by human hematological components. , 1972, Cancer research.

[8]  J. Brown,et al.  The role of phosphohydrolases in the mechanism of resistance of neoplastic cells to 6-thiopurines. , 1971, Cancer research.

[9]  C. D. Steuart,et al.  Cytidine deaminase and the development of resistance to arabinosyl cytosine. , 1971, Nature: New biology.

[10]  R. Adamson.  METABOLISM OF ANTICANCER AGENTS IN MAN , 1971, Annals of the New York Academy of Sciences.

[11]  N. Bachur,et al.  Daunorubicin metabolism by rat tissue preparations. , 1971, The Journal of pharmacology and experimental therapeutics.

[12]  N. Bachur.  Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions. , 1971, The Journal of pharmacology and experimental therapeutics.

[13]  N. Sládek.  Metabolism of cyclophosphamide by rat hepatic microsomes. , 1971, Cancer research.

[14]  M. J. Sweeney,et al.  Possible in Situ Activation of Mycophenolic Acid by β-Glucuronidase , 1971 .

[15]  N. Bachur,et al.  Daunomycin metabolism in rat tissue slices. , 1970, The Journal of pharmacology and experimental therapeutics.

[16]  A. S. Gordon,et al.  Nucleoside deaminase: an enzymatic marker for stress erythropoiesis in the mouse. , 1970, The Journal of clinical investigation.

[17]  F. Šorm,et al.  Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. , 1970, Cancer research.

[18]  J L Cohen,et al.  Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. , 1970, The Journal of pharmacology and experimental therapeutics.

[19]  G. Bryan,et al.  Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man. , 1970, Biochemical pharmacology.

[20]  J Morrow,et al.  Genetic analysis of azaguanine resistance in an established mouse cell line. , 1970, Genetics.

[21]  M. Colvin,et al.  The enzymatic reduction of hydroxyurea to urea by mouse liver. , 1970, Cancer research.

[22]  J. Hadfield,et al.  The binding of vinblastine by platelets in the rat. , 1970, Cancer research.

[23]  R. Adamson,et al.  The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals. , 1970, Cancer research.

[24]  A. Schrecker.  Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts. , 1970, Cancer research.

[25]  D. Kessel,et al.  Retention of 6-mercaptopurine derivatives by intact cells as an index of drug response in human and murine leukemias. , 1969, Cancer research.

[26]  P. Reyes,et al.  Synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice. , 1969, Biochemical pharmacology.

[27]  B. Dewald,et al.  N-demethylation of p-(N1-methylhydrazion methyl)-N-isopropyl benzamide (procarbazine), a cytostatically active methylhydrazine derivative, in the intact rat and in the isolated perfused rat liver. , 1969, Biochemical pharmacology.

[28]  B. Dewald,et al.  Oxidation of p-(N1-methylhydrazino methyl)-N-isopropyl benzamide (procarbazine) to the methylazo derivative and oxidative cleavage of the N2-C bond in the isolated perfused rat liver. , 1969, Biochemical pharmacology.

[29]  Yamamoto Itaru.  4 (or 5)-diazoimidazole-5 (or 4)-carboxamide and related triazenoimidazoles as antibacterial agents: their effects on nucleic acid metabolism of Escherichia coli B. , 1969 .

[30]  T. L. Loo,et al.  Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide. , 1969, Life sciences.

[31]  T. Krenitsky.  Tissue distribution of purine ribosyl- and phosphoribosyltransferases in the Rhesus monkey. , 1969, Biochimica et biophysica acta.

[32]  D. Smithers,et al.  Resistance to 4-aminopyrazolo (3,4-d) pyrimidine. , 1969, Biochemical pharmacology.

[33]  G. Lepage,et al.  Nucleotide Formation from α- and β-2′-Deoxythioguanosine in Extracts of Murine and Human Tissues , 1969 .

[34]  D. Rosenthal,et al.  Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro. , 1969, Cancer research.

[35]  S. Gartler,et al.  Development of a nonselective technique for studying 2, 6, diaminopurine resistance in an established murine cell line. , 1968, Genetics.

[36]  E. Frei,et al.  Distribution of purine ribonucleoside kinase and selective toxicity of 6-methyl thiopurine ribonucleoside. , 1968, Biochemical pharmacology.

[37]  R. Koshiura,et al.  Some Inhibitors of Deamination of 9-β-d-Arabinofuranosyladenine and 9-β-d-Xylofuranosyladenine by Blood and Neoplasms of Experimental Animals and Humans , 1968 .

[38]  R. Dixon.  Effect of Chloramphenicol on the Metabolism and Lethality of Cyclophosphamide in Rats∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[39]  E. Frei,et al.  Clinical pharmacologic observations on 6‐mercaptopurine and 6‐methylthiopurine ribonucleoside , 1968, Clinical pharmacology and therapeutics.

[40]  C. T. Beer,et al.  The preparation of vinblastine-4-acetyl-t and its distribution in the blood of rats. , 1968, Journal of medicinal chemistry.

[41]  J. Seegmiller,et al.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. , 1967, JAMA.

[42]  A. Paterson,et al.  Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor. , 1967, Cancer research.

[43]  B. Kennedy,et al.  Studies with tritiated mithramycin in C3H mice. , 1967, Cancer research.

[44]  C. G. Smith,et al.  Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. , 1967, Biochemical pharmacology.

[45]  J. G. Simpson,et al.  Studies of the Mode of Action of N-Isopropyl-α-(2-methylhydrazino)-p-toluamide , 1967 .

[46]  I. Wodinsky,et al.  Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine Arabinoside , 1967, Science.

[47]  J. F. Henderson,et al.  Resistance to purine ribonucleoside analogues in an ascites tumor. , 1967, Canadian journal of biochemistry.

[48]  I. Wodinsky,et al.  Nucleotide Formation as a Determinant of 5-Fluorouracil Response in Mouse Leukemias , 1966, Science.

[49]  J. Montgomery,et al.  Activity of adenos1ne analogs against a cell culture, line resistant to 2-fluoroadenine , 1966 .

[50]  H. Weissbach,et al.  Studies on the disposition of actinomycin D-3H in virus-infected and tumor-bearing mice. , 1966, Cancer research.

[51]  A. W. Murray.  Purine-phosphoribosyltransferase activities in rat and mouse tissues and in Ehrlich ascites-tumour cells. , 1966, The Biochemical journal.

[52]  T. A. Connors,et al.  Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour Sensitivity , 1966, Nature.

[53]  A. Seligman,et al.  Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration. , 1966, Cancer research.

[54]  D. Blair,et al.  The metabolism of 2,6-diaminopurine by diaminopurine-sensitive and diaminopurine-resistant L-strain mouse fibroblasts. , 1965, Canadian journal of biochemistry.

[55]  R. Adamson,et al.  The distribution, excretion and metabolism of hydroxyurea-C14. , 1965, The Journal of pharmacology and experimental therapeutics.

[56]  E. Henderson,et al.  The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys. , 1965, Cancer research.

[57]  E. Henderson,et al.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.

[58]  R. Adamson,et al.  The metabolite of 3', 5'-dichloro-4-amino-4-deoxy-N10-methylpteroylglutamic acid (dichloromethotrexate). , 1965, Journal of medicinal chemistry.

[59]  V. Oliverio,et al.  The physiologic disposition of dichloromethotrexate‐CI36 in man , 1965, Clinical pharmacology and therapeutics.

[60]  V. Potter,et al.  PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. I. SUSPENSION CELL CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA. , 1965, Cancer research.

[61]  A. Sartorelli,et al.  THE METABOLISM OF THIOGUANINE IN PURINE ANALOG-RESISTANT CELLS. , 1964, Cancer research.

[62]  J. Brink,et al.  METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES. , 1964, Cancer research.

[63]  G. Lepage,et al.  BIOCHEMICAL AND CARCINOSTATIC EFFECTS OF 2'-DEOXYTHIOGUANOSINE. , 1964, Cancer research.

[64]  J. Brink,et al.  METABOLIC EFFECTS OF 9-D-ARABINOSYLPURINES IN ASCITES TUMOR CELLS. , 1964, Cancer research.

[65]  A. Sartorelli,et al.  THE BIOCHEMICAL BASIS FOR THE DIFFERENTIAL SENSITIVITY OF INTESTINAL MUCOSA AND BONE MARROW TO 6-THIOGUANINE. , 1963, Cancer research.

[66]  C. Heidelberger,et al.  EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY. , 1963, Cancer research.

[67]  G. P. Warwick.  THE MECHANISM OF ACTION OF ALKYLATING AGENTS. , 1963, Cancer research.

[68]  G. Hitchings,et al.  RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES. , 1963, Cancer research.

[69]  D. R. Dubbs,et al.  DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE. , 1963, Experimental cell research.

[70]  E. Henderson,et al.  THE DISTRIBUTION, EXCRETION, AND METABOLISM OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE-C14. , 1963, The Journal of pharmacology and experimental therapeutics.

[71]  C. Heidelberger,et al.  STUDIES OF FLUORINATED PYRIMIDINES. XVIII. THE DEGRADATION OF 5-FLUORO-2'-DEOXYURIDINE AND RELATED COMPOUNDS BY NUCLEOSIDE PHOSPHORYLASE. , 1963, Biochemistry.

[72]  D. B. Ellis,et al.  Biochemical Studies of Resistance to 6-Thioguanine , 1963 .

[73]  R. W. Brockman,et al.  A biochemical basis for resistance of L1210 mouse leukemia to 6-thioguanine. , 1963, Biochemical pharmacology.

[74]  L. Révész,et al.  Studies on resistance against 5-fluorouracil. III. Selective value of resistant, uridine kinase-deficient tumor cells. , 1962, Cancer research.

[75]  J. Montgomery,et al.  Antitumor activity of triazenoimidazoles. , 1962, Biochemical pharmacology.

[76]  P. K. Smith,et al.  The metabolism of 1-aminocyclopentane-1-carboxylic acid in normal and neoplastic tissues. , 1962, Biochemical pharmacology.

[77]  M. Jones,et al.  Further studies on the mechanism of action of 6-thioguanine. , 1961, Cancer research.

[78]  J. Wyngaarden,et al.  6-Mercaptopurine as substrate and inhibitor of xanthine oxidase , 1961 .

[79]  R. W. Brockman.  A mechanism of resistance to 6-mercaptopurine: metabolism of hypoxanthine and 6-mercaptopurine by sensitive and resistant neoplasms. , 1960, Cancer research.

[80]  G. Lepage.  Incorporation of 6-thioguanine into nucleic acids. , 1960, Cancer research.

[81]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14. , 1960, The Journal of biological chemistry.

[82]  J. Davidson.  Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L1210 leukemia in vitro. , 1960, Cancer research.

[83]  H. Skipper,et al.  A mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms. , 1959, Cancer research.

[84]  G. Klein,et al.  Possible Enzymic Mechanism for the Development of Resistance against Fluorouracil in Ascites Tumours , 1959, Nature.

[85]  A. Sartorelli,et al.  Metabolic effects of 6-thioguanine. I. Studies on thioguanine-resistant and-sensitive Ehrlich ascites cells. , 1958, Cancer research.

[86]  E. C. Moore,et al.  The metabolism of 6-thioguanine in normal and neoplastic tissues. , 1958, Cancer research.

[87]  E. Trams,et al.  Studies on the N-dealkylation of nitrogen mustard and triethylenemelamine by liver homogenates. , 1956, Cancer research.

[88]  E. Trams,et al.  Distribution of radiocarbon in liver chlorine, creatine, and methionine after the injection of methyl-C14-bis (beta-chloroethyl) amine. , 1955, Cancer research.

[89]  A. Gellhorn,et al.  Laboratory and clinical studies on 8‐azaguanine , 1953, Cancer.

[90]  J. Kream,et al.  Enzymatic deamination of 8-azaguanine in normal and neoplastic tissues. , 1952, Cancer research.

[91]  W. Kreis.  Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm. , 1970, Cancer research.

[92]  G. Lepage.  Alterations in enzyme activity in tumors and the implications for chemotherapy. , 1970, Advances in enzyme regulation.

[93]  M. Burch,et al.  Studies on the uptake of tubeidin (7-deazaadenosine) by blood cells and its distribution in whole animals. , 1970, Cancer research.

[94]  G. Bryan,et al.  N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man. , 1970, Cancer research.

[95]  G. Lepage,et al.  METABOLISM OF PURINE NUCLEOSIDE ANALOGS. , 1965, Cancer research.

[96]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XVI. Metabolism of 5-Fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine-2-C14 in Cancer Patients , 1963 .

[97]  R. W. Brockman,et al.  MECHANISMS OF RESISTANCE TO ANTICANCER AGENTS. , 1963, Advances in cancer research.

[98]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XVII. Tissue Distribution of 5-Fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine in Cancer Patients , 1963 .

[99]  N. Morris,et al.  Studies concerning the inhibition of cellular reproduction by deoxyribonucleosides: I. Inhibition of the synthesis of deoxycytidine by a phosphorylated derivative of thymidine , 1963 .

[100]  R. Handschumacher,et al.  Alterations in pyrimidine metabolism in L5178Y leukemia cells resistant to 6-azauridine. , 1961, Cancer research.

[101]  R. W. Brockman,et al.  Metabolism of uracil and 5-fluorouracil by drug-sensitive and by drug-resistant bacteria. , 1960, Biochimica et biophysica acta.